/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, October 14,.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) invites to a conference call on the supporting clinical data from the completed dose escalation section of.
(PLX AI) - Medivir positive study results of MIV-818 in HCC dose escalation section of the phase 1b study.• The overall safety profile was in line with expectations for this type of drug and patient population